Continued growth….
Following design and development in concert with recognised specialists, AES Medical Ltd has integrated four new cancer site modules into the latest development version of PathoSys®.

These modules will shortly be available to all current users to trial in their training environments and to new PathoSys® customers.
The new PathoSys® modules:

  • Central Nervous System
  • Lymphoma – based on the RC Path dataset and expanded to cover additional test results.
  • Ovarian – based on the latest RC Path dataset.
  • Penile

This brings the total number of specimen types covered by PathoSys® to thirty three.